The global ”bone void fillers market“ size is expected to exhibit exponential growth owing to the increasing prevalence of bone-associated disease across the globe. Fortune Business Insights, published this information in its latest report, titled “Bone Void Fillers Market Size, Share & Industry Analysis, By Type (Demineralized Bone Matrix (DBM), Collagen Matrix, Calcium Sulfate, Tri-calcium Phosphate, and Others), By Form (Gel, Granules, Paste, Putty, and Others), By End User (Hospitals, Specialty Clinics and Others), and Regional Forecast, 2020-2027.” The report mentions that the market is likely to generate USD 3.90 billion by 2027, while exhibiting a CAGR of 5.4% between 2020 and 2027. Furthermore, the report observes that the market was worth USD 2.80 billion in 2019.
Request a Sample Copy of the Research Report:
Bone void fillers are mainly used to fill gaps and voids present in the bone owing to injuries, trauma, and benign bone tumors, among others. Increasing incidence of bone-associated diseases is driving the demand for the products across the globe. In addition to this, the surging demand for synthetic bone void fillers owing to several advantages, such as high sterility and extensive availability of raw material across the globe is set to drive the growth of the market during the forecast period. According to the National Center for Biotechnology Information (NCBI), every year, it is estimated that about 1.5 million people suffer a fracture owing to a bone disease.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations travel bans and quarantines restaurants closed all indoor events restricted over forty countries state of emergency declared massive slowing of the IT Spending market volatility falling business confidence, growing panic among the population, and uncertainty about future.
Out research methodology is robust and includes data triangulation based on bottom-up and top-down approaches. We validated the approximate market number with the help of primary research. Secondary research was conducted to find out detailed information about mergers & acquisitions, collaborations, joint ventures, and agreements. At the same time, we have derived significant information about the market dynamics associated with growth drivers, trends, and obstacles.
- April 2020: Biocomposites, an international medical device company, announced that it has received a new CE Mark from the European Union for its product, STIMULAN. According to the company, the product is beneficial for treating and the effective management of infected bone and soft tissue.
For more information in the analysis of this report, visit: